By Steve Jenkinson, VP Drug Discovery and Safety Assessment, Metrion Biosciences
Metrion Biosciences provides GLP hERG testing services which crucial for drug discovery and the Investigational New Drug (IND) process. Our focus is on delivering reliable, regulatory-compliant data quickly and cost-effectively.
Our investment in advanced electrophysiology platforms and highly trained scientists ensures data is robust, reproducible, and meets regulatory standards worldwide. A particular strength is rapid turnaround time, supporting the fast-paced drug discovery process without compromising quality.
Competitive pricing makes GLP hERG testing accessible to companies of all sizes, particularly benefiting smaller biotech firms and academic institutions, without compromising on quality.
Read more about our high-quality, cost-effective and rapid-turnaround, GLP testing against hERG.